FDA Grand Rounds: FDA’s Color Certification Program - Regulation and Research
June 13, 2024
Zoom Webinar
The FDA Grand Rounds highlights cutting-edge research underway across the agency and its impact on protecting and advancing public health. Each session features an FDA scientist presenting on a key public health challenge and how FDA is applying science to its regulatory activities.
The U.S. Food and Drug Administration (FDA) regulates color additives under the authority of the Federal Food, Drug, and Cosmetic Act. Color additives must be pre-approved by the FDA and listed in Title 21 of the Code of Federal Regulations before they may be used in FDA-regulated products. The presentation will explain the color additive petition process and how a color additive is listed for use in FDA-regulated products. We will also give a detailed look into FDA's color certification process. The presentation will discuss research topics related to the certification of the color additives.
- Color Additives: https://www.fda.gov/industry/color-additives
- Color Additive Laws, Regulations, and Guidance: https://www.fda.gov/industry/color-additives/color-additive-laws-regulations-and-guidance
- Color Additive Science and Research: https://www.fda.gov/industry/color-additives/color-additive-science-and-research
- Discuss the research conducted at the FDA
- Explain how FDA science impacts public health
- Describe a color additive.
- Identify certified color additives.
- Explain how a color additive gets listed.
- Explain certification process for color additives.
- Discuss certification research related topics.
This activity is intended for physicians, pharmacists, nurses, and other scientists within the agency and external scientific communities.
Registration is complimentary; therefore refunds are not applicable. For information on how to register to attend this activity, please contact the Activity Coordinator(s) listed above.
Lecture 1 June 13, 2024
Time | Topic | Speaker |
---|---|---|
12:00 - 1:00 PM EDT | FDA’s Color Certification Program - Regulation and Research | Bhakti Petigara Harp, PhD |
![Jointly Accredited Provider](https://ceportal.fda.gov//files/content/docs/logo-joint-accreditation-provider.png)
![ICPE Credit](https://ceportal.fda.gov//files/content/docs/icpeCreditLogo.png)
All learners claiming credit must attest to their attendance and complete all required activity evaluation(s) in the FDA CE Portal (ceportal.fda.gov) within 14 days after an activity ends. Upon completion, learners may view/print statement of credit.
Attention NABP Pharmacists and Pharmacy Technicians: The FDA CE Team will report your credit to the National Association of Boards of Pharmacy (NABP) provided you add your NABP ID and date of birth to your profile in the FDA CE Portal. The only official Statement of Credit is the one you pull from CPE Monitor. If you do not see your credit reflected on CPE Monitor* after 45 days of attestation, please contact FDACETeam@fda.hhs.gov. *CPE Monitor sets a strict 60-day limit on uploading credits.
Faculty
- Petigara Harp, Bhakti, PhD, Research Chemist, FDA, Center for Food Safety and Applied Nutrition - nothing to disclose
Planning Committee
- Dinatale, Miriam, DO, Team Leader, Food and Drug Administration - nothing to disclose
- Pfundt, Tiffany, PharmD, Program Coordinator, FDA/CDER/OTBB - nothing to disclose
- Shahidzadeh, Rokhsareh, RN, MSN, Senior Regulatory Health Education Specialist, FDA - nothing to disclose
CE Consultation and Accreditation Team
- Faberlle, Alexandra M., Training Specialist / FDA/CDER/OEP/DLOD - nothing to disclose
- Bryant, Traci, M.A.T., Lead Training Specialist, FDA/CDER/OEP/DLOD - nothing to disclose
- Wood, Sara, Accreditation Program Administrator, CECAT, FDA/CDER/OEP/DLOD - nothing to disclose
All relevant financial relationships have been mitigated.